Table 1.
Condition/Disease | Status | Phase | Treatment | Trial number |
---|---|---|---|---|
Parkinson's disease | Completed | 2 | Mitoquinone | NCT00329056 |
Stroke | Completed | 2 | Cyclosporin A | NCT01527240 |
Glucose metabolism disorders | Active, not recruiting | Not applicable | NMN | NCT03151239 |
Progressive supranuclear palsy Neurological disorders | Completed | 2 and 3 | CoQ10 | NCT00532571 |
Sleep disorder Traumatic brain injury | Withdrawn | 2 | Tesamorelin | NCT02931474 |
Mild cognitive impairment | Recruiting | 1 | Niagen® | NCT03482167 |
Friedreich's ataxia | Completed | 3 | Idebenone | NCT01303406 |
Brain tumor treated with cranial or cranial-spinal radiation | Completed | 3 | Metformin | NCT02040376 |
Cerebral infarction | Completed | 4 | Edaravone | NCT00200356 |